🔎 Trials Near Me

Home › Overweight › North Carolina › Havelock

Overweight clinical trials in Havelock, NC

17 studies for Overweight are looking for participants at sites in and around Havelock (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 2
  • Centricity Research - Morehead city /ID# 283264, Morehead City · 15 mi away
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07752979

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RecruitingPhase 3
  • West Clinical Research, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RecruitingPhase 3
  • Lucas Research, Inc, Morehead City · 15 mi away
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RecruitingPhase 3
  • West Clinical Research, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RecruitingPhase 3
  • Carteret Medical Group, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • West Clinical Research, Morehead City · 15 mi away
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Lucas Research, Inc, Morehead City · 15 mi away
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 3
  • AURORA-1 Clinical Site, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3
  • AURORA-2 Clinical Site, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RecruitingPhase 3
  • Centricity Research Morehead City Multispeciality, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RecruitingPhase 2
  • Lucas Research, Inc., Morehead City · 15 mi away
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RecruitingPhase 3Healthy volunteers welcome
  • ACCOMPLISH-2 Research Site, Morehead City · 15 mi away
Ages 18 to 79 · All sexes · Updated Sep 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Lucas Research, Inc, Morehead City · 15 mi away
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RecruitingPhase 3
  • Kailera Clinical Site, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

RecruitingPhase 3
  • Kailera Clinical Site, Morehead City · 15 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RecruitingPhase 3
  • West Clinical Research, Morehead City · 15 mi away
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RecruitingPhase 3
  • Centricity Research Morehead City Specialty, Morehead City · 15 mi away
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399

Overweight trials in other cities

Other studies in Havelock

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.